TickerFacts.

Adagio Medical Holdings, Inc. (ADGM): R&D Expense

Annual figures by period end, from SEC filings.

$10.64M
Year ended 2025-12-31
$10.20M
Trailing 12 months to 2026-06-30
$15.40M2023-12-31: $15.40M2025-12-31: $10.64M$10.64M
2023-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$10.64Mn/a2026-03-27, From 2025-01-01
No annual figure between 2023-12-31 and 2025-12-31.
2023-12-31$15.40Mn/a2025-03-27, From 2023-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Adagio Medical Holdings, Inc. (ADGM)2025-12-31$10.64Mn/a
Baxter International Inc (BAX)2025-12-31$518.00M-12.2%
Becton Dickinson & Co (BDX)2025-09-30$1.26B+6.3%
3M Co (MMM)2024-12-31$700.00M0.0%
Teleflex Inc (TFX)2025-12-31$144.78M+32.8%
West Pharmaceutical Services Inc (WST)2025-12-31$74.30M+7.5%
Stryker Corp (SYK)2025-12-31$1.62B+10.7%
Haemonetics Corp (HAE)2026-03-28$59.77M-4.7%
KORU Medical Systems, Inc. (KRMD)2025-12-31$4.39M-16.6%

Compare ADGM, BAX, BDX, MMM side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗